Schedule 13G ownership disclosure

Gemphire Therapeutics Inc.

Security class unavailable · CUSIP: 36870A108

Event date: 2018-08-10

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,383,290
Percent of class
9.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-18-052817
Form type
SC 13G
Filer
MetaVia Inc.
CIK
CIK 1638287
Filed
Aug 20, 2018
Reporting period
Aug 10, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub